TherapeuticsMD, Inc. (NYSEMKT:TXMD) Files An 8-K Regulation FD Disclosure
Item 7.01.
| Regulation FD Disclosure. |
TherapeuticsMD, Inc. is furnishing as Exhibit 99.1 to this
Current Report on Form 8-K an investor presentation which will be
used, in whole or in part, and subject to modification, on June
1, 2017 and at subsequent meetings with investors or analysts.
The information in this Current Report on Form 8-K (including the
exhibit) is being furnished to Item 7.01 of Form 8-K and shall
not be deemed to be filed for the purpose of Section 18 of the
Securities Exchange Act of 1934, as amended, or otherwise subject
to the liabilities of that section, nor will any of such
information or exhibits be deemed incorporated by reference into
any filing under the Securities Act of 1933, as amended, or the
Securities Exchange Act of 1934, as amended, except as expressly
set forth by specific reference in such filing.
| Item 9.01. | Financial Statements and Exhibits. |
| (d) | Exhibits. | ||
| Exhibit | |||
| Number | Description | ||
| 99.1 | TherapeuticsMD, Inc. presentation dated June 2017. |
About TherapeuticsMD, Inc. (NYSEMKT:TXMD)
TherapeuticsMD, Inc. is a women’s healthcare company engaged in creating and commercializing products for women. The Company is focused on pursuing regulatory approvals and pre-commercialization activities necessary for commercialization of its hormone therapy pharmaceutical products. Its drug candidates used in clinical trials are designed to alleviate symptoms of and reduce health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis and vaginal discomfort. With its SYMBODA technology, it is developing hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through dosage forms and administration routes. Its product line includes vitaTrue, vitaPearl, vitaMedMD Plus, vitaMedMD One Prenatal Multivitamin, vitaMedMD Plus Rx Prenatal Multivitamin, vitaMedMD One Rx Prenatal Multivitamin, vitaMedMD Iron 21/7, vitaMedMD Vitamin D3 50,000 IU, BocaGreenMD Prena1 Pearl and BocaGreenMD Prena1 Chew. TherapeuticsMD, Inc. (NYSEMKT:TXMD) Recent Trading Information
TherapeuticsMD, Inc. (NYSEMKT:TXMD) closed its last trading session up +0.31 at 4.15 with 2,036,929 shares trading hands.
